|
| Title |
|
|
|
Removal of the N-glycosylation sequon at position N116 located in p27 of the respiratory syncytial virus fusion protein elicits enhanced antibody responses after DNA immunization
| |
| Author |
|
|
|
| |
| Abstract |
|
|
| | |
| Language |
|
|
|
English
| |
| Source (journal) |
|
|
|
Viruses | |
| Publication |
|
|
|
2018
| |
| ISSN |
|
|
|
1999-4915
| |
| Volume/pages |
|
|
|
10:8(2018), 20 p.
| |
| Article Reference |
|
|
|
426
| |
| ISI |
|
|
|
000443619600037
| |
| Pubmed ID |
|
|
|
30110893
| |
| Medium |
|
|
|
E-only publicatie
| |
| Full text (Publisher's DOI) |
|
|
| | |
| Full text (open access) |
|
|
| | |
|
| Faculty/Department |
|
|
|
| |
| Research group |
|
|
|
| Project info |
|
|
|
Characterisation of a novel Respiratory Syncytial Virus (RSV) immune evasion mechanism and evaluation of the impact for development of novel vaccines and prophylactic and/or therapeutic antibodies Improved respiratory syncytial virus (rsv) vaccines based on glycan modification of the viral fusion (f) protein.
| Publication type |
|
|
| | | |
| Subject |
|
|
|
| | |
| Affiliation |
|
|
|
Publications with a UAntwerp address
| |
|
|
|
| Identification |
|
| |
|
|
| Creation |
|
| |
06.09.2018
|
|
| Last edited |
|
| |
23.03.2020
|
|
| To cite this reference |
|
|
| | |
|
| |